| NDC Code: |
14537-966 |
| Proprietary Name: |
AS |
| Suffix: |
3 |
| Non-Proprietary Name: |
Dextrose Monohydrate, Sodium Citrate, Sodium Chloride, Sodium Phosphate, Monobasic, Monohydrate, Citric Acid Monohydrate and Adenine |
| Dosage Form: |
INJECTION, SOLUTION |
| Method: |
INTRAVENOUS |
| Original Marketing Date: |
29-05-2002 |
| Category Name: |
NDA |
| Application Number: |
BN001214 |
| Labeler: |
TERUMO BCT LTD |
| Substance Name: |
ADENINE; CITRIC ACID MONOHYDRATE; DEXTROSE MONOHYDRATE; SODIUM CHLORIDE; SODIUM CITRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE |
| Active Numerator Strength: |
.03; .042; 1.1; .41; .588; .276 |
| Active Ingredient Unit: |
g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL |
| Pharm Classes: |
Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |
| DEA Schedule: |
|
